Andrew D. White

Also affiliated with Edison Pharmaceuticals (United States), Institute for the Future, University of Rochester

Biochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Author Correction: AI is a viable alternative to high throughput screening: a 318-target study”.

Author Correction: AI is a viable alternative to high throughput screening: a 318-target study

Scientific Reports(2024)10.1038/s41598-024-70321-w

N/A

0.165DataRank · unranked

2 citations

Izhar Wallach, Denzil Bernard, Kong T. Nguyen, Gregory Ho, Adrian R. Morrison +95 more

Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidines as atypical protein kinase C inhibitors to control retinal vascular permeability and cytokine-induced edema

Bioorganic & Medicinal Chemistry(2020)10.1016/j.bmc.2020.115480

N/A

0DataRank · unranked

2 citations

Michael W. Wilson, Kun Liu, Pil H. Lee, Larisa Yeomans, Susan E. Hagen +7 more

The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor

Blood(2023)10.1182/blood.2023020622

N/A

0DataRank · unranked

19 citations

Adriana Yamaguchi, Pooja Yalavarthi, Sylviane Lambert, Devin Gilmore, Andrew Rickenberg +8 more

Effects of two structurally diverse positive allosteric modulators on signaling bias at the μ-opioid receptor

Molecular Pharmacology(2025)10.1016/j.molpha.2025.100079

N/A

0DataRank · unranked

1 citations

Kelsey Kochan, M. Alexander Stanczyk, H. C. Stewart, Joshua L. West, Andrew D. White +4 more